Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.05%3.12B | 2.34%3.18B | 1.21%3.21B | -0.02%12.68B | 0.04%3.28B | 0.71%3.13B | -0.54%3.11B | -0.29%3.17B | 87.24%12.68B | 50.16%3.27B |
| Cost of revenue | 12.84%814.35M | 11.15%812.27M | 13.82%852.93M | 7.07%3.02B | 1.47%814.26M | 13.64%721.71M | 13.55%730.79M | 749.39M | 61.08%2.82B | 802.48M |
| Gross profit | -3.92%2.31B | -0.38%2.37B | -2.69%2.36B | -2.05%9.66B | -0.43%2.46B | -2.61%2.4B | -4.19%2.38B | 2.42B | 96.34%9.87B | 2.47B |
| Operating expense | -5.25%1.29B | -8.86%1.26B | -14.04%1.3B | 2.83%5.95B | 26.68%1.55B | -6.27%1.36B | -12.62%1.38B | 65.32%1.52B | 135.08%5.79B | -21.19%1.22B |
| Staff costs | -8.38%187.88M | -21.15%175.87M | -29.76%248.67M | 2.41%919.26M | -45.29%134.64M | -4.50%205.08M | 2.03%223.04M | --354.01M | 185.60%897.65M | --246.11M |
| Selling and administrative expenses | -2.66%157.24M | -4.14%166.52M | 0.81%171.49M | -6.69%670.21M | -10.73%164.85M | -2.63%161.54M | -11.38%173.72M | --170.1M | 80.29%718.26M | --184.65M |
| -Selling and marketing expense | -2.66%157.24M | -4.14%166.52M | 0.81%171.49M | -6.69%670.21M | -10.73%164.85M | -2.63%161.54M | -11.38%173.72M | --170.1M | 80.29%718.26M | --184.65M |
| Depreciation and amortization | -5.87%699.82M | -9.18%681.66M | -14.96%653.75M | 1.03%3.26B | 83.37%1B | -14.71%743.44M | -16.27%750.58M | -16.11%768.79M | 131.03%3.23B | 12.53%545.69M |
| -Depreciation | -5.65%646.69M | -8.13%625.08M | -15.26%602.49M | 0.71%3.02B | 93.78%940.3M | -16.58%685.42M | -18.92%680.42M | -22.41%711.02M | 130.36%3B | 25.27%485.23M |
| -Amortization | -8.42%53.14M | -19.36%56.58M | -11.28%51.26M | 5.20%246.3M | -0.20%60.34M | 15.98%58.02M | 22.59%70.16M | --57.78M | 139.88%234.13M | --60.46M |
| Rent and land expenses | 19.59%103.73M | 5.76%84.61M | 62.98%119.63M | 12.34%322.92M | 66.08%92.82M | 119.82%86.73M | -14.60%80.01M | --73.4M | 175.09%287.45M | --55.89M |
| Other operating expenses | -14.00%144.56M | -2.30%148.97M | -26.87%108.79M | 18.56%775.6M | -18.60%153.23M | 2.24%168.08M | -12.60%152.48M | --148.76M | 165.19%654.21M | --188.24M |
| Operating profit | -2.18%1.02B | 11.38%1.11B | 16.28%1.05B | -8.97%3.71B | -26.85%915.61M | 2.64%1.04B | 10.60%995.32M | -59.96%906.49M | 59.12%4.08B | 212.11%1.25B |
| Net non-operating interest income (expenses) | 5.69%-143.19M | 0.60%-142.5M | 5.45%-141.17M | -9.96%-597.75M | -21.93%-152.77M | -11.34%-151.84M | -5.31%-143.36M | -5.75%-149.31M | -144.19%-543.6M | -123.35%-125.3M |
| Non-operating interest income | 59.30%5.68M | 89.30%4.92M | -16.19%2.85M | -85.56%12.84M | -84.26%3.27M | -84.86%3.57M | -89.18%2.6M | -83.43%3.4M | 160.80%88.89M | 44.32%20.77M |
| Non-operating interest expense | -4.20%148.88M | 0.99%147.41M | -5.69%144.02M | -3.46%610.58M | 6.83%156.03M | -2.84%155.4M | -8.86%145.96M | -5.57%152.71M | 146.39%632.49M | 107.22%146.06M |
| Net investment income | -87.95%1.92M | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | -89.74%473K | 117.83%4.61M | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 2K | |||||||||
| Income from associates and other participating interests | 83.11%-2.1M | -57.65%3.62M | -175.51%-1.98M | -24.96%23.29M | -15.70%6.16M | -192.87%-12.43M | 197.98%8.54M | -64.87%2.63M | 31.04M | 7.31M |
| Special income (charges) | -217.2M | -217.2M | 0 | 0 | ||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | --217.2M | --217.2M | ---- | ---- | ---- | --0 | --0 |
| Other non-operating income (expenses) | -37.31%-369.48M | -9.45%-372.38M | -7.61%-357.85M | 14.71%-1.18B | 18.28%-370.77M | 15.33%-269.08M | -14.02%-340.22M | 80.27%-332.55M | -41.06%-1.39B | -133.02%-453.73M |
| Income before tax | -17.16%502.49M | 14.80%597.3M | 29.45%553.06M | -20.39%1.74B | -73.38%181.03M | 5.97%606.56M | 11.10%520.28M | -7.18%427.25M | 64.03%2.18B | 218.67%680.03M |
| Income tax | -8.15%152.52M | 51.79%158.52M | 193.57%164.95M | -43.58%346.44M | -91.79%19.76M | 46.20%166.06M | -13.26%104.44M | -59.72%56.19M | 27.56%614.05M | 180.16%240.57M |
| Net income | -20.55%349.97M | 5.52%438.78M | 4.59%388.11M | -11.30%1.39B | -63.30%161.27M | -3.99%440.5M | 19.54%415.84M | 15.67%371.07M | 84.74%1.57B | 244.59%439.47M |
| Net income continuous operations | -20.55%349.97M | 5.52%438.78M | 4.59%388.11M | -11.30%1.39B | -63.30%161.27M | -3.99%440.5M | 19.54%415.84M | 15.67%371.07M | 84.74%1.57B | 244.59%439.47M |
| Noncontrolling interests | 148.21%8.74M | -101.62%-159K | 180.46%4.34M | -16.67%12.19M | -1.88%4.24M | 14.76%3.52M | 125.04%9.82M | -287.22%-5.39M | 8,405.81%14.63M | 2,409.88%4.32M |
| Net income attributable to the company | -21.91%341.23M | 8.11%438.94M | 1.94%383.78M | -11.25%1.38B | -63.91%157.04M | -4.11%436.98M | 18.20%406.02M | 18.41%376.46M | 83.05%1.55B | 241.67%435.15M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -21.91%341.23M | 8.11%438.94M | 1.94%383.78M | -11.25%1.38B | -63.91%157.04M | -4.11%436.98M | 18.20%406.02M | 18.41%376.46M | 83.05%1.55B | 241.67%435.15M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -21.77%0.0291 | 8.09%0.0374 | 1.87%0.0327 | -11.36%0.117 | -63.88%0.0134 | -4.12%0.0372 | 18.09%0.0346 | 18.45%0.0321 | 26.92%0.132 | 228.32%0.0371 |
| Diluted earnings per share | -21.77%0.0291 | 8.09%0.0374 | 1.87%0.0327 | -11.36%0.117 | -63.88%0.0134 | -4.12%0.0372 | 18.09%0.0346 | 18.45%0.0321 | 26.92%0.132 | 241.75%0.0371 |
| Dividend per share | 8.57%0.038 | 5.71%0.037 | 5.71%0.037 | 10.16%0.141 | 9.09%0.036 | 9.38%0.035 | 9.38%0.035 | 12.90%0.035 | -1.54%0.128 | -2.94%0.033 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.